Antares Pharma Inc (ATRS)

3.73 -0.02  -0.53% NASDAQ Oct 22, 16:00 3.73 0.00  0.00% After-Hours: 20:00 USD
View Full Chart
Price Chart
View All ATRS News

News

View All Events

Events

Date Type Description
11/04/2021 Earnings Results Q3 2021 Earnings Results
11/04/2021 08:30 EST Earnings Calls Q3 2021 Earnings Call
08/05/2021 Earnings Results Q2 2021 Earnings Results
08/05/2021 08:30 EST Earnings Calls Q2 2021 Earnings Call
06/10/2021 10:00 EST AGM 2020 Annual General Meeting
05/06/2021 Earnings Results Q1 2021 Earnings Results
05/06/2021 08:30 EST Earnings Calls Q1 2021 Earnings Call
03/02/2021 Earnings Results Q4 2020 Earnings Results
03/02/2021 08:30 EST Earnings Calls Q4 2020 Earnings Call
11/05/2020 08:30 EST Earnings Calls Q3 2020 Earnings Call
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • Description: Antares Pharma Inc is a specialty pharmaceutical company. It is focused on the development and commercialization of self-administered parenteral pharmaceutical products and technologies. The company's products include OTREXUP, Elestrin, Gelnique, Makena, and others.
  • URL: https://www.antarespharma.com
  • Investor Relations URL: https://www.antarespharma.com/investors/press
  • HQ State/Province: New Jersey
  • Sector: Healthcare
  • Industry: Medical Instruments & Supplies
  • Equity Style: Small Cap/Growth
  • Next Earnings Release: Nov. 04, 2021
  • Last Earnings Release: Aug. 05, 2021
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A

Top Fund Holders

Symbol Name Weighting
PDFDX Perkins Discovery 2.42%

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.